Article in Genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Qing WeiDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Avenue, Z5.5048, Houston, TX 77030, USA.
Gokce A TorunerDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Avenue, Z5.5048, Houston, TX 77030, USA.ORCID 0000-0002-5305-6337
Beenu ThakralDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Avenue, Z5.5048, Houston, TX 77030, USA.ORCID 0000-0001-5140-3633
Keyur P PatelDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Avenue, Z5.5048, Houston, TX 77030, USA.
Naveen PemmarajuDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Avenue, Z5.5048, Houston, TX 77030, USA.ORCID 0000-0002-1670-6513
Sa A WangDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Avenue, Z5.5048, Houston, TX 77030, USA.
Rashmi Kanagal-ShamannaDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Avenue, Z5.5048, Houston, TX 77030, USA.ORCID 0000-0001-7829-5249
Guilin TangDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Avenue, Z5.5048, Houston, TX 77030, USA.ORCID 0000-0002-9482-4806
Ghayas C IssaDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Avenue, Z5.5048, Houston, TX 77030, USA.ORCID 0000-0002-4339-8683
Sanam LoghaviDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Avenue, Z5.5048, Houston, TX 77030, USA.ORCID 0000-0001-8980-3202
L Jeffrey MedeirosDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Avenue, Z5.5048, Houston, TX 77030, USA.ORCID 0000-0001-6577-8006
Courtney DiNardoDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Avenue, Z5.5048, Houston, TX 77030, USA.ORCID 0000-0001-9003-0390
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
background
methodsWe present a case of a 22-year-old woman with acute monoblastic leukemia harboring a cryptic
resultsTo resolve these discrepancies, metaphase
conclusionsThis case highlights the importance of integrating multiple testing modalities with expert review when there is a discrepancy. Our findings emphasize the need for a comprehensive approach to genomic assessment to enhance diagnostic accuracy and guide therapeutic decision-making.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.